Senior Research Scientist, Taipei Medical University, Taiwan
He is working as Working as Senior Research Scientist, Department of Pharmacology, Graduate Institute of Medical Sciences, Taipei Medical University, Taipei, Taiwan. He was Granted Outstanding Scientist Award from 2012 to 2017 by Taipei Medical University, Taipei, Taiwan. He has published more than 70 research and review papers.
Stroke is a main cause of mortality and morbidity globally but current therapeutic approach for the inhibition of brain injury in patients with cerebral ischemia is lacking. Though tissue plasminogen activator (t-PA) has been used to treat stroke patients, this therapeutic strategy is confronted with ill side effects and is limited to patients within 3 hours of a stroke. Due to the difficulty of the events and the unsatisfactory results from single agent trials, the combination of thrombolytic therapy and effective neural protection therapy may be an alternative strategy for patients with cerebral ischemia. Traditional Chinese medicine (TCM) is the most widely practiced form of herbalism worldwide, as it is a sophisticated system of medical theory different from Western medicine. Most traditional therapeutic formulations consist of a combination of several drugs.